(R)-7-(2,2-difluoro-1-phenylethyl)-5,5-dimethyl-2-(phenylamino)-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one

ID: ALA3885257

PubChem CID: 134130107

Max Phase: Preclinical

Molecular Formula: C22H20F2N4O

Molecular Weight: 394.43

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1(C)C(=O)N([C@H](c2ccccc2)C(F)F)c2nc(Nc3ccccc3)ncc21

Standard InChI:  InChI=1S/C22H20F2N4O/c1-22(2)16-13-25-21(26-15-11-7-4-8-12-15)27-19(16)28(20(22)29)17(18(23)24)14-9-5-3-6-10-14/h3-13,17-18H,1-2H3,(H,25,26,27)/t17-/m1/s1

Standard InChI Key:  HUHRXBBSMSZINZ-QGZVFWFLSA-N

Molfile:  

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    4.1396  -19.6250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0347  -21.6019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4474  -20.8962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6299  -20.8916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0557  -22.2646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7638  -22.6735    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4734  -22.2641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4706  -21.4414    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0569  -21.4450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7641  -21.0354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5931  -20.2361    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7800  -20.1518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9403  -19.7986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3714  -19.4441    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1818  -22.6716    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8888  -22.2619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5939  -22.6698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3004  -22.2608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2996  -21.4427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5863  -21.0354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8826  -21.4468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1899  -20.5786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9892  -20.7497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5382  -20.1419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2823  -19.3603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4837  -19.1929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8874  -18.8477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4344  -18.2406    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.0881  -18.6775    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  1  0
  4  3  1  0
  9  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8 10  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  3  1  0
  3  9  1  0
  1 13  1  0
 11  1  1  0
 12 14  2  0
  7 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 13 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 13  1  0
  1 27  1  1
 27 28  1  0
 27 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3885257

    ---

Associated Targets(Human)

MARK3 Tchem Serine/threonine-protein kinase c-TAK1 (2532 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MARK4 Tchem MAP/microtubule affinity-regulating kinase 4 (1536 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 394.43Molecular Weight (Monoisotopic): 394.1605AlogP: 4.85#Rotatable Bonds: 5
Polar Surface Area: 58.12Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.07CX Basic pKa: 0.73CX LogP: 5.08CX LogD: 5.08
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.67Np Likeness Score: -0.80

References

1. Katz JD, Haidle A, Childers KK, Zabierek AA, Jewell JP, Hou Y, Altman MD, Szewczak A, Chen D, Harsch A, Hayashi M, Warren L, Hutton M, Nuthall H, Su HP, Munshi S, Stanton MG, Davies IW, Munoz B, Northrup A..  (2017)  Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors.,  27  (1): [PMID:27816515] [10.1016/j.bmcl.2016.08.068]

Source